Jensen, M. H.
, Kjolby, M., Hejlesen, O., Jakobsen, P. E. & Vestergaard, P. (2020).
Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality for Widely Used Antihyperglycemic Dual and Triple Therapies for Type 2 Diabetes Management: A Cohort Study of All Danish Users. Diabetes Care,
43(6), 1209-1218.
https://doi.org/10.2337/dc19-2535Jeppesen, P. B., Beck, T. K., Kristensen, H. L., Kjeldsen, C., Strand, M., Mandrup, P.
& Kidmose, U. (2020).
Kålkogebogen: spis bitterstoffer fra kål og rodfrugter og slip for type 2 diabetes. Gyldendal.
Jepsen, S. L.
, Vestergaard, E. T., Larraufie, P., Gribble, F. M., Reimann, F.
, Jørgensen, J. O. L., Holst, J. J. & Kuhre, R. E. (2020).
Ghrelin does not directly stimulate secretion of glucagon-like peptide-1.
The Journal of clinical endocrinology and metabolism,
105(1), 266-275. Article dgz046.
https://doi.org/10.1210/clinem/dgz046Kanstrup, C., Teilum, D.
, Rejnmark, L., Bigaard, J. V., Eiken, P., Kroman, N., Tjønneland, A. & Mejdahl, M. K. (2020).
25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
Breast Cancer Research and Treatment,
179(3), 699-708.
https://doi.org/10.1007/s10549-019-05486-4Keller, K. K., Thomsen, J. S., Stengaard-Pedersen, K., Therkildsen, J., Nielsen, A. W., Schiøtz-Christensen, B., Svendsen, L., Graakjær, M.
, Petersen, P. M., Unger, B.
, Kjær, S. G., Langdahl, B. L. & Hauge, E. M. (2020).
Évolution à un an de la maladie érosive chez des patients arthralgiques ayant des anticorps anti-peptides cycliques citrullinés.
Revue du Rhumatisme,
87(5), 409-411.
https://doi.org/10.1016/j.rhum.2020.02.005
Keller, K. K., Thomsen, J. S., Stengaard-Pedersen, K., Therkildsen, J., Nielsen, A. W., Schiøtz-Christensen, B., Svendsen, L., Graakjær, M.
, Petersen, P. M., Unger, B., Kjær, S. G., Langdahl, B. L. & Hauge, E. M. (2020).
One-year progression of erosive disease in patients with anti-citrullinated peptide antibodies and arthralgia.
Joint Bone Spine,
87(2), 181-183.
https://doi.org/10.1016/j.jbspin.2019.09.006
Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T.
, Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020).
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Blood,
136(24), 2754-2763.
https://doi.org/10.1182/blood.2020007247Kjaergaard, A. D., Helby, J., Johansen, J. S., Nordestgaard, B. G. & Bojesen, S. E. (2020).
Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population.
Clinical Microbiology and Infection,
26(10), 1411.e1-1411.e9.
https://doi.org/10.1016/j.cmi.2020.01.010